Akari Therapeutics (AKTX) Free Cash Flow (2014 - 2026)

Akari Therapeutics (AKTX) posted quarterly Free Cash Flow of -$2.5 million for Q1 2026, down 15.72% year-on-year from -$3.0 million in Q1 2025, and up 18.18% on a QoQ basis from -$3.0 million in Q4 2025.

Akari Therapeutics (AKTX) Free Cash Flow (2014 - 2026) Analysis & Trends

Akari Therapeutics (AKTX) has reported Free Cash Flow for 9 consecutive years, with -$2.5 million the latest figure, recorded in Q1 2026.

  • Quarterly Free Cash Flow fell 15.72% year-over-year to -$2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.9 million (down 2.33% YoY) and the FY2025 annual result came in at -$10.6 million, up 15.81% from the prior year.
  • Free Cash Flow improved to -$2.5 million in Q1 2026 per AKTX's latest filing, from -$3.0 million in the prior quarter.
  • Over the last five years, Free Cash Flow for AKTX reached as high as -$1.5 million in Q3 2024 and fell as low as -$4.9 million in Q2 2024.
  • A 4-year average of -$3.2 million and a median of -$3.0 million in 2025 frame the typical range for Free Cash Flow.
  • Annual changes were most pronounced in 2024 — Free Cash Flow surged 51.83% — and 2025, when it slumped 43.17%.
  • Year by year, Free Cash Flow stood at -$4.4 million in 2023, then jumped by 51.83% to -$2.1 million in 2024, then sank by 43.17% to -$3.0 million in 2025, then climbed by 18.18% to -$2.5 million in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods registered -$2.5 million, -$3.0 million, and -$2.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -19.58 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 158.09 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.53 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.29 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 848.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -354.95 Mn
10 Akari Therapeutics 86.55 Mn 86.55 Mn - -2.49 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.49 Mn
Mar 31, 2026 -2.49 Mn
Dec 31, 2025 -3.04 Mn
Dec 31, 2025 -3.04 Mn
Sep 30, 2025 -2.12 Mn
Sep 30, 2025 -2.12 Mn
Jun 30, 2025 -3.26 Mn
Jun 30, 2025 -3.26 Mn
Mar 31, 2025 -2.15 Mn
Mar 31, 2025 -2.15 Mn
Dec 31, 2024 -2.12 Mn
Dec 31, 2024 -2.12 Mn
Sep 30, 2024 -1.49 Mn
Sep 30, 2024 -1.49 Mn
Jun 30, 2024 -4.89 Mn
Jun 30, 2024 -4.89 Mn
Mar 31, 2024 -4.04 Mn
Mar 31, 2024 -4.04 Mn
Dec 31, 2023 -4.41 Mn
Dec 31, 2023 -4.41 Mn